Leongamornlert, Daniel

Careers | Find us | Contact us

About
About
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways.
- Our Vision
  Our Vision
  The Wellcome Sanger Institute is a world leader in genome research that delivers insights into human and pathogen biology that change science and medicine.
- Impact
  Impact
  Sanger Institute’s history.
- Careers
  Careers
  Join our community of world class thinkers and professionals at the Sanger Institute located in Cambridge. Together we achieve life-changing science.
- Study
  Study
  We are committed to training the next generation of pioneering genome scientists and clinicians At the Wellome Sanger Institute, near Cambridge, we give students all the tools they need to succeed in the field of genomics research.
- Equality, Diversity and Inclusion
  Equality, Diversity and Inclusion
  Women are represented in diminishing proportions as career levels progress and significant numbers of women leave science altogether. Scientists from marginalised groups such as LGBT+, BME and disabled scientists also do not achieve success at the same rates as their counterparts. With partners on the Wellcome Genome Campus we explore these issues, look to inspire researchers, develop discussion and drive change in current practices and policy.
- Leadership
  Leadership
  The Director, Matthew Hurles, has overall responsibility for all areas of the Sanger Institute, reporting to GRL Board three times per year and the Wellcome Trust Board of Governors once per year.
- Strategy and Funding
  Strategy and Funding
  The Sanger Institute’s mission is to use information from genome sequences to advance understanding of biology and improve health.
- Influencing Policy
  Influencing Policy
  The Sanger Institute advises all levels of government both in the UK and across the world on the the role, impact and importance of genomic and life science research.
- Research Policies
  Research Policies
  Sanger Institute’s Research Policies are designed to provide guidance to help researchers navigate the legislation relating to their research and to ensure that research is ethical and legal.
- Branding and Logos
  Branding and Logos
  Wellcome Sanger Institute Branding Guidelines and Logos.
- Admin Groups
  Admin Groups
  Management and support operations groups.
- Campus Connections
  Campus Connections
  The Sanger Institute is sited on the Wellcome Genome Campus at the very heart of a global hub of fundamental and applied genomic research, education and engagement. The Campus is home to some of the world’s foremost institutes and organisations using genomes and biodata to deliver science with the reach, scale and imagination to solve some of humanity’s greatest challenges and maximise societal benefit
Science
Science
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease or analytic focus. In all cases, the studies provide insights into human, pathogen, cellular evolution, the phenotypic and hence biological consequences of genome variation and the processes which cause mutations.
- Groups
  Groups
  Scientific and Faculty groups.
- Programmes
  Programmes
  Wellcome Sanger Institute research programmes.
- Collaborations
  Collaborations
  Collaborations with external partners.
- Tools
  Tools
  Wellcome Sanger Institute tools directory.
- Data
  Data
  Wellcome Sanger Institute data resources.
- Sanger Projects
  Sanger Projects
  A list of research projects at the Wellcome Sanger Institute.
- Publications
  Publications
  The Sanger Institute has published papers in some of the most prestigious scientific journals. We aim to publish research that will transform biology and improve healthcare.
- Research Policies
  Research Policies
  Sanger Institute’s Research Policies are designed to provide guidance to help researchers navigate the legislation relating to their research and to ensure that research is ethical and legal.
- COVID-19
  COVID-19
  The Sanger Institute’s contribution to research into COVID-19, including sequencing the SARS-CoV-2 virus.
- Sanger Seminar Series
  Sanger Seminar Series
  Throughout the COVID-19 lockdown of 2020-2021 we hosted a series of monthly freely available and open virtual seminars, showcasing how our researchers are tackling some of the greatest challenges in human health and disease. From using genomic approaches to map all cell types in the human body, understand how cancer develops, and track the evolution and spread of global diseases, our senior scientists and faculty presented the latest developments in their field.
People
People
Almost 1,000 scientists, developers, engineers and skilled professionals work together to deliver the Sanger Institute’s cutting-edge genomic research.
- Leadership
  Leadership
  The Sanger Leadership Team is an Executive Committee that reports to the Director and the Genome Research Limited (GRL) Board. It is designed to enable holistic and effective decision making, with transparency and accountability woven into its make up.
- Faculty
  Faculty
  Our science is organised into five Scientific Programmes, each defining a major area of research with a particular biological, disease or analytic focus. In all cases, the studies provide insights into human, pathogen, cellular evolution, the phenotypic and hence biological consequences of genome variation and the processes which cause mutations.
- Associate Faculty
  Associate Faculty
  Our science is organised into five Scientific Programmes, each defining a major area of research with a particular biological, disease or analytic focus. In all cases, the studies provide insights into human, pathogen, cellular evolution, the phenotypic and hence biological consequences of genome variation and the processes which cause mutations.
- Honorary Faculty
  Honorary Faculty
  Our science is organised into five Scientific Programmes, each defining a major area of research with a particular biological, disease or analytic focus. In all cases, the studies provide insights into human, pathogen, cellular evolution, the phenotypic and hence biological consequences of genome variation and the processes which cause mutations.
- International Fellows
  International Fellows
  The Wellcome Sanger Institute’s International Fellows Programme, designed to empower early-career researchers from LMICs with resources, mentorship, and funding to advance genomic research globally.
- Science Staff
  Science Staff
  From PhD students and Postdoctoral Fellows, bioinformaticians and laboratory managers, these staff the support the delivery of pioneering science.
- Non-science Staff
  Non-science Staff
  Non-science Staff.
- Full A-Z
  Full A-Z
  Almost 1,000 scientists, developers, engineers and skilled professionals work together to deliver the Sanger Institute’s cutting-edge genomic research.
Innovation
Innovation
We deliver therapeutic, diagnostic and production benefits in areas as diverse as cancer, immunology, public health and personalised treatment.
- Innovation at the Institute
  Innovation at the Institute
  We deliver therapeutic, diagnostic and production benefits in areas as diverse as cancer, immunology, public health and personalised treatment.
- For Industry
  For Industry
  Our translation team was established in 2011 to help maximise the socioeconomic impact of the Sanger Institute’s discoveries. Members of this team specialise in helping to translate science into products and services and the Institute’s research has already produced marketed technologies that have been realised into benefits for patients in a variety of settings.
- For Researchers
  For Researchers
  The Sanger Institute has always sought to facilitate improvements in human health. As the Institute continues to generate an ever deeper biological understanding of the genomic data and engender clinical perspectives to its science it will be faced with even greater opportunities to contribute to healthcare improvements.
- Case Studies
  Case Studies
  We engage with the funding, R&D, service and clinical communities to promote real-world utilization of the Sanger Institute’s technologies and resources.
- Our Spin-Outs
  Our Spin-Outs
  The Institute has a culture and history of scaling technologies, some of these capabilities have become spin-out companies that represent an important step towards the creation of a positive impact in today’s healthcare sector.
- Sanger Technologies
  Sanger Technologies
  We create technologies and therapies of tomorrow through open dialogue with our many partners.
News
News
Wellcome Sanger Institute News.

Dr Daniel Leongamornlert

Staff Scientist

Nangalia Group
Clonal trajectories and epigenetics

Dan is interested in the role of structural variants and mutational signatures in cancer.

Dan is a staff scientist in the Nangalia Group working on and supporting projects studying myeloproliferative neoplasms (MPN) and chronic myeloid leukaemia (CML).

Wellcome Sanger Institute

Programmes and Facilities

Programme

Cancer, Ageing and Somatic Mutation

The Cancer, Ageing and Somatic Mutation Programme pioneers data aggregation and informatics innovation, develops high-throughput cellular models of cancer for genome-wide ...

About

Our Vision

Impact

Careers

Study

Equality, Diversity and Inclusion

Leadership

Strategy and Funding

Influencing Policy

Research Policies

Branding and Logos

Admin Groups

Campus Connections

Science

Groups

Programmes

Collaborations

Tools

Data

Sanger Projects

Publications

Research Policies

COVID-19

Sanger Seminar Series

People

Leadership

Faculty

Associate Faculty

Honorary Faculty

International Fellows

Science Staff

Non-science Staff

Full A-Z

Innovation

Innovation at the Institute

For Industry

For Researchers

Case Studies

Our Spin-Outs

Sanger Technologies

News

Dr Daniel Leongamornlert

Programmes and Facilities

Cancer, Ageing and Somatic Mutation